[PDF] Top 20 Tailored therapy for severe asthma

... In asthma, the response against aeroallergens is mainly based on the inflammatory response of T lymphocytes, with an important involvement of IL-1β in the inflamma- tory signal ...allergic asthma patients, ... See full document

... of asthma activity, increases during exacerbations and responds to ...with severe therapy resistant asthma compared to peripheral blood [32], while severe asthmatics also had higher ... See full document

... Notes: Binding of iL-5 to the α subunit of the iL-5 receptor (iL-5Rα) promotes the heterodimerization of iL-5Rα and βc subunits. As a consequence, many signal transduction pathways are activated, including JAK/STAT ... See full document

... and asthma control test (ACT) were ...ard therapy together with any changes, and adverse events were recorded (Table ...3. Asthma diagnosis and severity were periodically reassessed according to GINA ... See full document

... biologic therapy, including tumour necrosis factor (TNF) inhibitors [6], tyrosine kinase inhibitors [5] and the cytotoxic T-lymphocyte antigen 4 blockade agent ipilimumab ... See full document

... in asthma treatment and management; however, there is still a population of patients who remain difficult to ...add-on therapy are proving effective in achieving asthma control in patients with ... See full document

... more severe categories of asthma, where the heterogeneity of the disease may really require a “personalized therapy” in the presence of a lack of adequate asthma control with the current ... See full document

... Abstract: Asthma is a disease of all ...of asthma in the most advanced ages is similar to that in younger ...ages. Asthma in the elderly may show similar functional and clinical characteristics to ... See full document

... add-on therapy for 6-year or older children with moderate to severe persist- ent asthma, in association with positive skin prick test or specific serum IgE to a perennial aeroallergen and ... See full document

... vere asthma involves recognition and aggressive appropriate therapy, with rapid escalation to ster- oid therapy as soon as indicated. Intubation with a nasotracheal [r] ... See full document

... driven asthma is the most common and best understood subphenotype of severe refractory ...a severe asthma attack have shown a high expression of the high-affinity IgE surface receptor on mast ... See full document

... asthma-specific instrument covering 4 domains: perception of medication index, control relief index, comparison with other medications index, and inhaler index (this last domain was not assessed, because all ... See full document

... Weekly sessions may have contributed to the high drop-out rate in the intervention group compared to the control group although an active control group also attending weekly study visits would be required to test this ... See full document

... maintenance therapy plus budesonide/formoterol ...reliever therapy, 2) budesonide/formoterol ...reliever therapy had a reduced risk of severe asthma exacerbations, need for sys- temic ... See full document

... add-on therapy for those patients: omalizumab, an anti-IgE monoclonal anti- body, and mepolizumab, an anti-IL5 monoclonal anti- body, approved and included in GINA Guidelines 2016 ... See full document

... in severe asthmatics with high periostin levels compared to those with low periostin levels, as demonstrated by an improvement in FEV 1 and a reduction in F eNO [145], thus providing an entirely new example of ... See full document

... opment of new treatments is urgently needed. Identifying dif- ferent phenotypes of bronchiectasis may help us in directing therapy toward specific target with better results compared to that actually expected by ... See full document

... aggressive therapy, our group felt that it was prudent to initi- ate treatment with close ...to therapy was the re- turn of symptoms and elevation of se- rum IgE level after discontinuation of ... See full document

... effective therapy to reduce blood and sputum eosinophils in severe prednisone-depend- ent asthma, with a good safety profile and low incidence of circulating anti-drug antibodies ... See full document

... for severe eosinophilic asthma, by both the US Food and Drug Administration (FDA) and the European Medicines Agency ...for Asthma guidelines, as an add-on therapy for severe ... See full document